Literatur
Baltzer AWA, Drever R, Granrath M, Godde G, Klein W, Wehling P (2003) Intraartikuläre Therapie der Gonarthrose mit autologem Interleukin-1-Rezeptor-Antagonist. Dtsch Z Sportmed 54: 209–211
Clark W, Jobanputra P, Barton P, Burls A (2004) The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis. Health Technol Assess 8(18): 1–132
Firestein GS, Boyle DL, Yu C, Paine MM, Whisenand TD, Zvaifler NJ, Arend WP (1994) Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 37: 644–652
Gerard N, Caillaud M, Martoriati A, Goudet G, Lalmanach AC (2004) The interleukin-1 system and female reproduction. J Endocrinol 180: 203–212
Horai R, Saijo S, Tanioka H et al. (2000) Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist deficient mice. J Exp Med 191: 313–320
Jenkins JK, Malyak M, Arend WP (1994) The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils. Lymphokine Cytokine Res 13: 47–54
Malyak M, Smith MF, Abel AA, Arend WP (1994) Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta. J Clin Immunol 14: 20–30
Meijer H, Reinecke J, Becker C, Tholen G, Wehling P (2003) The production of antiinflammatory cytokines in whole blood by physico-chemical induction. Inflamm Res 52: 404–407
Wehling P, Cleveland SJ, Heininger K, Schulitz KP, Reinecke J, Evans CH (1996) Neurophysiologic changes in lumbar nerve root inflammation in the rat after treatment with cytokine inhibitors. Spine 21: 931–935
Wehling P, Kassel A, Reinecke J, Meijer H, Granrath M, Godde D, Baltzer A (2003) Aktueller Stand der Gentherapie und Biotechnologie in der Orthopädie. Extracta Orthop 26: 10–16
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stengel, D., Ekkernkamp, A. & Wich, M. Intraartikuläre Therapie mit autologem Interleukin-1-Rezeptor-Antagonist bei Arthrose. Unfallchirurg 107, 1103–1106 (2004). https://doi.org/10.1007/s00113-004-0885-9
Issue Date:
DOI: https://doi.org/10.1007/s00113-004-0885-9